Acuitas
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6190 Agronomy Rd Unit 402, Vancouver, Br...Phone Number
(604) 227-3904Website
www.acuitastx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Acuitas
Acuitas Therapeutics is a global leader in lipid nanoparticle (LNP) delivery systems, dedicated to advancing human health through strategic partnerships. The company focuses on supporting its partners in the development of nucleic acid therapeutics, from preclinical optimization to commercialization. With a commitment to innovation, Acuitas has contributed to numerous clinical trials and publications, showcasing the effectiveness of its LNP technology. Their mission is to enable the successful delivery of therapeutics for a variety of diseases, including cancer and genetic disorders.Explore more
Acuitas Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acuitas your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Acuitas, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Acuitas recently announced quarterly report
Click to see if Acuitas had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Acuitas has new funding data
Congratulate Masked Content for being promoted to Masked Content at Acuitas
Check if Acuitas has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Acuitas launches new products
Check out if Acuitas is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Acuitas
Compare insights from companies similar to Acuitas, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acuitas is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Acuitas is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Acuitas.
Acuitas Tech Stack
A closer look at the technologies used by Acuitas
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Facilities Relocation / Expansion
Acuitas is planning to move offices in June 2025. The move will impact approximately 15 employees at the existing office located at 6190 Agronomy Road, Suite #405, Vancouver, BC.
Facilities Relocation/Expansion
Open Position
Open Position
Acuitas News & Media
Aldevron Announces Strategic Partnership with Acuitas Therapeutics
FARGO, N.D. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, today announced it has entered a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNPs). This partnership will allow Aldevron to expand its capabilities in mRNA LNP eReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas’ LNP formulations
ReciBioPharm, the advanced and emerging therapies business unit within Recipharm, and biotechnology firm Acuitas Therapeutics have today announced they are taking their partnership to the next level, and are ready to perform technology transfers and CGMP manufacturing for customers licensing Acuitas’ lipid nanoparticle (LNP) formulations for mRNA-based therapeutics and vaccines. ReciBioPharm first partnered with Acuitas Therapeutics in May of 2022 as Arranta Bio (now part of ReciBioPharm) and haBIOVECTRA Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (LNP) Delivery System Used in Manufacturing mRNA-Based Therapies
CHARLOTTETOWN, Prince Edward Island & VANCOUVER, British Columbia--(BUSINESS WIRE)-- #Acuitas--BIOVECTRA will formulate Acuitas’ LNP for licensed therapeutic partners for clinical and commercial products using a variety of payloads.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Acuitas
Sign Up For FreeTo access detailed company insights
Acuitas Therapeutics is a global leader in lipid nanoparticle (LNP) delivery systems, dedicated to advancing human health through strategic partnerships. The company focuses on supporting its partners in the development of nucleic acid therapeutics, from preclinical optimization to commercialization. With a commitment to innovation, Acuitas has con... Read More
